Unknown

Dataset Information

0

Liquid crystal delivery of ciprofloxacin to treat infections of the female reproductive tract.


ABSTRACT: Infections of the female reproductive tract are a major cause of morbidity and mortality in humans, requiring significant investment to sustain treatment and representing a major challenge to health. The increasing prevalence of bacterial resistance, and an almost complete absence of new antibiotic therapies for the past five decades, mean there is a desperate need for novel approaches to the treatment of bacterial infections. Within the present study, we demonstrate the effective ex vivo treatment of bacterial infection of the female reproductive tract using a controlled-release, liquid crystal-based platform. Liquid crystal encapsulation of ciprofloxacin significantly enhanced its bactericidal efficacy and reduced cell toxicity. Liquid crystal structures are low-cost, simple to manufacture and provide a sustained-release profile of encapsulated ciprofloxacin. Treatment of Escherichia coli infected reproductive tract epithelial cells and whole organ cultures with liquid crystal encapsulated ciprofloxacin proved to be an effective strategy for reducing bacterial load and reproductive tract inflammatory responses to infection. These data suggest that such an approach could provide an efficacious treatment modality for enhancing the effectiveness of current antibiotic therapies.

SUBMITTER: Pisano S 

PROVIDER: S-EPMC6439215 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Liquid crystal delivery of ciprofloxacin to treat infections of the female reproductive tract.

Pisano Simone S   Giustiniani Matteo M   Francis Lewis L   Gonzalez Deyarina D   Margarit Lavinia L   Sheldon I Martin IM   Paolino Donatella D   Fresta Massimo M   Conlan R Steven RS   Conlan R Steven RS   Healey Gareth D GD  

Biomedical microdevices 20190329 2


Infections of the female reproductive tract are a major cause of morbidity and mortality in humans, requiring significant investment to sustain treatment and representing a major challenge to health. The increasing prevalence of bacterial resistance, and an almost complete absence of new antibiotic therapies for the past five decades, mean there is a desperate need for novel approaches to the treatment of bacterial infections. Within the present study, we demonstrate the effective ex vivo treatm  ...[more]

Similar Datasets

| S-EPMC4810082 | biostudies-literature
| S-EPMC10985838 | biostudies-literature
| S-EPMC3328984 | biostudies-literature
| S-EPMC5712241 | biostudies-literature
| S-EPMC6177736 | biostudies-literature
| S-EPMC9362696 | biostudies-literature
2020-12-29 | GSE143759 | GEO
| S-EPMC10321600 | biostudies-literature
| S-EPMC8060646 | biostudies-literature
2023-05-11 | GSE228359 | GEO